THIMBLE POINT ACQUISITION-A (THMA) Stock News

Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Prescription Digital Therapeutics Company

Mentions: PEAR

Pear Therapeutics to Participate in Evercore ISI Fourth Annual HealthCONx Conference

Pear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use Disorder

Pear Therapeutics Provides 2021 Business Update and Reaffirms Full Year 2021 Revenue Guidance

Thimble Point and Pear Therapeutics Announce Additional $50 Million in Committed Capital to Fund Business Plan

Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the November 2021 MassHealth Drug List Summary Update and MassHealth Non-Drug Product List

Pear Therapeutics to Participate in the BTIG Digital Health Forum

November SPAC Merger Calendar: Upcoming Votes, Earnings, Stocks To Watch

The month of November shows a continued slowdown in SPAC merger deal votes, but the calendar includes several multibillion-dollar deals. SPAC merger votes can act as a catalyst,...

Mentions: SOFI PAE MAPS ASTR ...

Pear and Thimble Point Announce Nominees to Board of Directors

14 SPACs That Palantir Technologies Has Invested In Or Partnered

Palantir Technologies Inc (NYSE: PLTR) is one of the most well-known publicly traded companies. The data analytics company is increasing its investments in the SPAC space,...

Mentions: MSFT VPCB GM ROT ...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Thimble Point Acquisition Corp. for Potential Breaches of Fiduciary Duty By Its Board of Directors

Palantir Has Quietly Become a Major SPAC Investor

The data analytics company has invested over $100 million in at least eight SPAC-related transactions, using the deals as a way to win business from emerging companies.

Mentions: PLTR QELL BLK ROT ...

Pear Therapeutics to Become a Public Company and Expand its Leadership Position in Prescription Digital Therapeutics

Thimble Point Acquisition Corp. Announces Pricing of Upsized $240 Million Initial Public Offering